{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:32:54Z","timestamp":1792834374342,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["ANR-22-PAUK-0033-01\/ANR-23-PAUK-9033-01"],"award-info":[{"award-number":["ANR-22-PAUK-0033-01\/ANR-23-PAUK-9033-01"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-10-EQPX1401"],"award-info":[{"award-number":["ANR-10-EQPX1401"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018696","name":"R\u00e9gion Normandie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003191","name":"R\u00e9gion Normandie","doi-asserted-by":"publisher","award":["00129360-22E04690"],"award-info":[{"award-number":["00129360-22E04690"]}],"id":[{"id":"10.13039\/501100003191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"National Centre for Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijrobp.2025.12.051","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T16:14:05Z","timestamp":1768493645000},"page":"1061-1074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proton Radiotherapy Offers Immune-Sparing Benefits in Glioblastoma Treatment"],"prefix":"10.1016","volume":"126","author":[{"given":"Julie","family":"Coupey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao Nguyen","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Toutain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriia","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika S.","family":"Hue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charly","family":"Helaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaric","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gael","family":"Simonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Moignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Valable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.12.051_bib0001","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41423-019-0211-7","article-title":"Innate lymphocytes-lineage, localization and timing of differentiation","volume":"16","author":"Kansler","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0002","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","article-title":"An overview of the immune system","volume":"357","author":"Parkin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0003","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0004","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0005","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1158\/0008-5472.CAN-05-3773","article-title":"Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma","volume":"66","author":"Fecci","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0006","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0007","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0008","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1038\/bjc.2014.162","article-title":"Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma","volume":"110","author":"Han","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0009","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1158\/1078-0432.CCR-12-1940","article-title":"Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers","volume":"19","author":"Prosniak","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0010","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0011","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0012","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","article-title":"Brain tumor microenvironment and host state: Implications for immunotherapy","volume":"25","author":"Tomaszewski","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0013","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41591-018-0135-2","article-title":"Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors","volume":"24","author":"Chongsathidkiet","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0014","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11060-019-03167-2","article-title":"Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma","volume":"143","author":"Kim","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0015","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-11-0774","article-title":"Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide","volume":"17","author":"Grossman","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0016","first-page":"1","article-title":"Early effects of different brain radiotherapy modalities on circulating leucocyte subpopulations in rodents","author":"Pham","year":"2024","journal-title":"Intl J Rad Bio"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0017","doi-asserted-by":"crossref","first-page":"eabn6758","DOI":"10.1126\/scitranslmed.abn6758","article-title":"Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma","volume":"15","author":"Ghosh","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0018","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0019","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13046-023-02621-4","article-title":"Beyond lymphopenia, unraveling Radiation-Induced leucocyte subpopulation kinetics and mechanisms through modeling approaches","volume":"42","author":"Pham","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/07357907.2012.762780","article-title":"The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0021","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11060-015-2037-1","article-title":"Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma","volume":"127","author":"Mendez","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0022","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab6c41","article-title":"4D blood flow model for dose calculation to circulating blood and lymphocytes","volume":"65","author":"Hammi","year":"2020","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0023","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/neuonc\/noaa182","article-title":"Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: Phase II randomized study of protons vs photons","volume":"23","author":"Mohan","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0024","first-page":"111","article-title":"Investigation of DNA damage and cell-cycle distribution in human peripheral blood lymphocytes under exposure to high doses of proton radiotherapy","volume":"10","author":"Miszczyk","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/laban1005-39","article-title":"A rapid, simple, and humane method for submandibular bleeding of mice using a lancet","volume":"34","author":"Golde","year":"2005","journal-title":"Lab Anim (NY)"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0026","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42826-021-00090-4","article-title":"Comparison of murine retroorbital plexus and facial vein blood collection to mitigate animal ethics issues","volume":"37","author":"Jo","year":"2021","journal-title":"Lab Anim Res"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0027","first-page":"76","article-title":"Effects on animal wellbeing and sample quality of 2 techniques for collecting blood from the facial vein of mice","volume":"54","author":"Francisco","year":"2015","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0028","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.mcb.2024.06.004","article-title":"Flow cytometry detection and quantification of circulating leukocyte subpopulations in mice after brain irradiation","volume":"189","author":"Coupey","year":"2024","journal-title":"Meth Cell Biol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0030","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1445951","article-title":"Systemic depletion of lymphocytes following focal radiation to the brain in a murine model","volume":"7","author":"Piotrowski","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0031","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3390\/ijms20133212","article-title":"Tumor Microenvironment as a \u2018Game Changer\u2019 in cancer radiotherapy","volume":"20","author":"Jarosz-Biej","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0032","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3390\/cells10092257","article-title":"The interplay between glioblastoma and Its microenvironment","volume":"10","author":"Dapash","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1438044","article-title":"Radiation immunodynamics in patients with glioblastoma receiving chemoradiation","volume":"15","author":"Sloan","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0034","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijrobp.2023.11.050","article-title":"Radiation therapy and myeloid-derived suppressor cells: Breaking down their cancerous partnership","volume":"119","author":"Bergerud","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0035","doi-asserted-by":"crossref","unstructured":"Kleinberg L, Sloan L, Grossman S, Lim M. 2019. Radiotherapy, lymphopenia, and host immune capacity in glioblastoma: A potentially actionable toxicity associated with reduced efficacy of radiotherapy. Neurosurgery. 2019;85:441-453.","DOI":"10.1093\/neuros\/nyz198"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0036","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1088\/1361-6560\/acaf45","article-title":"Roadmap for Precision preclinical x-ray radiation studies","volume":"68","author":"Verhaegen","year":"2023","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0037","article-title":"Late side effects in normal mouse brain tissue after proton irradiation","volume":"10","author":"Suckert","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0038","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170278","article-title":"El-missiry MA. Radiation induced bystander effects in the spleen of cranially-irradiated rats","volume":"90","author":"Mohye El-Din","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0039","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijrobp.2007.09.039","article-title":"In vivo bystander effect: Cranial X-irradiation leads to elevated DNA damage, altered cellular proliferation and apoptosis, and increased p53 levels in shielded spleen","volume":"70","author":"Koturbash","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1201500","article-title":"A review on lymphocyte radiosensitivity and its impact on radiotherapy","volume":"13","author":"Paganetti","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0041","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1021\/acs.jproteome.2c00544","article-title":"Plasma olink proteomics identifies CCL20 as a novel predictive and diagnostic inflammatory marker for preeclampsia","volume":"21","author":"Wang","year":"2022","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0042","article-title":"Olink proteomics analysis uncovers the landscape of inflammation-related proteins in patients with acute compartment syndrome","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0043","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1773-035X(18)30052-2","article-title":"Cytokines et inflammation : physiologie, physiopathologie et utilisation th\u00e9rapeutique","volume":"2018","author":"Noack","year":"2018","journal-title":"Revue Francophone des Laboratoires"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0044","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/09553000903419346","article-title":"Irradiation induces regionally specific alterations in pro-inflammatory environments in rat brain","volume":"86","author":"Lee","year":"2010","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3340\/jkns.2007.41.3.200","article-title":"Expression of cytokines in radiation injured brain at acute phase","volume":"42","author":"Lee","year":"2007","journal-title":"J Korean Neurosurg Soc"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0046","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.canrad.2024.08.001","article-title":"Differential plasma cytokine variation following X-Ray or proton brain irradiation using Machine-Learning approaches","volume":"28","author":"Pham","year":"2024","journal-title":"Cancer Radio: J Soc Franc Radio Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0047","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41467-023-35957-8","article-title":"Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma","volume":"14","author":"Zhou","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0048","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3390\/cancers13061468","article-title":"Charged particle and conventional radiotherapy: Current implications as partner for immunotherapy","volume":"13","author":"Marcus","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0049","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.canrad.2023.06.017","article-title":"[Radiation-induced lymphopenia: Lymphocytes as a new organ at risk]","volume":"27","author":"Laurent","year":"2023","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1448658","article-title":"Editorial: Updates on radiation-induced lymphopenia","volume":"14","author":"Damen","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.12.051_bib0051","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.3390\/ijms25115774","article-title":"Revolutionizing glioblastoma treatment: A comprehensive overview of modern therapeutic approaches","volume":"25","author":"Sadowski","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:33:18Z","timestamp":1792737198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0360301626000106"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.12.051","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Radiotherapy Offers Immune-Sparing Benefits in Glioblastoma Treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.12.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}